AI
EVH icon

Atom Investors’s Evolent Health EVH Stock Holding History

Atom Investors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$689K Buy
302,406
+33,206
+12% +$105K 0.05% 423
2025
Q4 		$1.08M Buy
+269,200
New +$1.5M 0.09% 285
2022
Q2 		– Sell
-9,158
Closed -$296K – 271
2022
Q1 		$296K Buy
+9,158
New +$240K 0.14% 142

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Atom Investors's EVH Position: Q1 2026 in Review

Atom Investors increased its Evolent Health (EVH) stake by 12% in Q1 2026, buying an estimated $105K and bringing the position to 302,406 shares worth $689K. The position accounts for 0.05% of the portfolio, ranked #423.

Atom Investors first reported a position in EVH in Q1 2022 and has held it in 3 quarters since. The position peaked at $1.08M in Q4 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Atom Investors held 302,406 shares of Evolent Health worth $689K as of Q1 2026.
  • Atom Investors bought 33,206 Evolent Health shares in Q1 2026, an estimated $105K.
  • Evolent Health made up 0.05% of Atom Investors's portfolio in Q1 2026, its #423 holding.
  • Atom Investors first reported a position in Evolent Health in Q1 2022 and has held it in 3 quarters since.
  • Atom Investors's Evolent Health position peaked at $1.08M in Q4 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.